KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Retained Earnings (2016 - 2025)

Historic Retained Earnings for Sarepta Therapeutics (SRPT) over the last 15 years, with Q3 2025 value amounting to -$4.6 billion.

  • Sarepta Therapeutics' Retained Earnings fell 621.31% to -$4.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.6 billion, marking a year-over-year decrease of 621.31%. This contributed to the annual value of -$4.2 billion for FY2024, which is 529.08% up from last year.
  • As of Q3 2025, Sarepta Therapeutics' Retained Earnings stood at -$4.6 billion, which was down 621.31% from -$4.5 billion recorded in Q2 2025.
  • Over the past 5 years, Sarepta Therapeutics' Retained Earnings peaked at -$3.0 billion during Q1 2021, and registered a low of -$4.7 billion during Q1 2025.
  • For the 5-year period, Sarepta Therapeutics' Retained Earnings averaged around -$4.0 billion, with its median value being -$4.4 billion (2024).
  • As far as peak fluctuations go, Sarepta Therapeutics' Retained Earnings tumbled by 3367.43% in 2023, and later soared by 529.08% in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Retained Earnings (Quarter) stood at -$3.2 billion in 2021, then fell by 21.94% to -$3.9 billion in 2022, then dropped by 13.71% to -$4.4 billion in 2023, then rose by 5.29% to -$4.2 billion in 2024, then dropped by 10.22% to -$4.6 billion in 2025.
  • Its Retained Earnings stands at -$4.6 billion for Q3 2025, versus -$4.5 billion for Q2 2025 and -$4.7 billion for Q1 2025.